• Sectors
    • Tech
    • Healthcare
    • Consumer
    • Energy
    • Mining & Metals
    • Business Services
    • Financials
    • Telecom
    • Industrials
    • Transportation
    • Aerospace & Defense
    • Real Estate
    • Utilities
  • Spotlight Stocks
  • CEO Interview
    • Investor Presentations
  • Newsmakers
  • Investing Strategy
    • Analyst Reports
    • Insider Trading
    • Smart Money
  • Funds & ETF’s
  • Markets
    • Commodities
    • Currencies
    • Economy
    • Lending & Interest Rates
  • Business News
    • Trading Ideas
  • Executive Resources
    • Leadership & Strategy
    • Capital
    • Law
  • Investor Education
    • Long Term Investing
    • Personal Finance
    • Stock Trading
    • Options Trading
    • Forex Trading
    • Futures Trading
  • Members
  • EVENTS
Newswire
  • [ August 23, 2019 ] Trump administration considers boost to biofuel mandates to ease farmer anger: sources Business News
  • [ August 23, 2019 ] Ghosts of 2002 ‘corralito’ spur Argentines to shun banks, stash cash at home Business News
  • [ August 23, 2019 ] The Top 3 Cannabis ETFs for 2019 and Beyond Trading Ideas
  • [ August 23, 2019 ] Trump tweetstorm sinks Wall Street as trade war rages on Business News
  • [ August 23, 2019 ] U.S. trade group says ‘unrealistic’ for American retailers to exit China Business News
  • [ August 23, 2019 ] Responding to Trump, UPS, FedEx say they already fight illegal drug shipments Business News
  • [ August 23, 2019 ] Trump comments on China spook Wall Street Business News
  • [ August 23, 2019 ] Trump orders U.S. firms out of China after Beijing sets new tariffs Business News
  • [ August 23, 2019 ] Oil dragged into U.S.-China trade war, prices slump Business News
  • [ August 23, 2019 ] For some, currency wars may not be fun or easy to win Business News
HomeBusiness NewsAfter damaging Reuters report, J&J doubles down on talc safety message

After damaging Reuters report, J&J doubles down on talc safety message

January 1, 2019 admin Business News Comments Off on After damaging Reuters report, J&J doubles down on talc safety message

Johnson & Johnson Inc’s statement was unequivocal.

…read more

Source:: Reuters – Business News

      

Add to my social media sites
SubscribeDiggdel.icio.usFacebookRedditStumbleUponTechnorati




Previous

After damaging Reuters report, J&J doubles down on talc safety message

Next

After damaging Reuters report, J&J doubles down on talc safety message

Featured Stocks

newsmakers

  • Medicine Man Technologies (OTC: MDCL) to Acquire One of Colorado’s Top Award-Winning and Best-Selling Edible Producers
    August 20, 2019 Comments Off on Medicine Man Technologies (OTC: MDCL) to Acquire One of Colorado’s Top Award-Winning and Best-Selling Edible Producers
  • NexTech (OTC: NEXCF) Raises $1,161,780 Insiders Purchase 277,916 Shares
    August 19, 2019 Comments Off on NexTech (OTC: NEXCF) Raises $1,161,780 Insiders Purchase 277,916 Shares
  • Phunware ( NASDAQ: PHUN) Announces Second Quarter 2019 Financial Results
    August 16, 2019 Comments Off on Phunware ( NASDAQ: PHUN) Announces Second Quarter 2019 Financial Results
  • Medicine Man Technologies (OTC: MDCL) Announces Record Second Quarter 2019 Results
    August 15, 2019 Comments Off on Medicine Man Technologies (OTC: MDCL) Announces Record Second Quarter 2019 Results
  • GP Solutions (OTC: GWPD) Named Top 7 Vertical Farming Companies
    August 15, 2019 Comments Off on GP Solutions (OTC: GWPD) Named Top 7 Vertical Farming Companies
  • CytoDyn (OTC: CYDY) Provides Update on Dose Escalating Trial with Leronlimab for HIV Monotherapy for a Potential Pivotal Trial
    August 15, 2019 Comments Off on CytoDyn (OTC: CYDY) Provides Update on Dose Escalating Trial with Leronlimab for HIV Monotherapy for a Potential Pivotal Trial
LEADERS

Phunware, Inc. (NASDAQ: PHUN): Next $100 Billion Company of Decentralized Computing era?

CytoDyn Inc. (OTC: CYDY) HIV therapy nearing FDA approval + drug pipeline with blockbuster potential

Chatham Rock Phosphate Limited (TSX.V: NZP) “Hundred Bagger” upside potential

The Yield Growth Corp. (CSE: BOSS) (OTC: BOSQF) Building brands “At the intersection of cannabis & wellness”

GP Solutions (OTC: GWPD) Indoor organic farming tech innovation addressing billion dollar markets

CytoDyn (OTC: CYDY) Monoclonal antibody HIV treatment w potential FDA approval in 2019

Medicine Man Technologies (OTC: MDCL) Vertically integrated cannabis operator, with growing revenues and profits

Cobalt27 (TSX.V: KBLT) (OTC: CBLLF) A “pure play” on electric vehicle boom

CytoDyn Inc. (OTC: CYDY) Monoclonal antibody for treating HIV and Cancer. Potential FDA approval for HIV in 2019

Elixinol Global Limited (ASX: EXL) (OTC: ELLXF) Emerging leader in CBD and Hemp foods and consumer products

  • Contact
  • About Us
  • Investor Relations Services
  • Terms of Use/Legal Notice
  • Become a Newsmaker
  • Login
  • Newsmakers Account
    • Subscriptions
    • Submit Press Release

Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.